Mary M Alleman1, Sarah A Meyer2, Audry Mulumba3, Michel Nyembwe3, Yogolelo Riziki4, Albert Mbule5, May Mayenga5, Tiekoura Coulibaly5. 1. Global Immunization Division. 2. Epidemic Intelligence Service Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. Expanded Programme on Immunization. 4. Institut National de Recherche Biomédicale, Ministry of Public Health. 5. Immunization, Vaccines, and Emergencies Cluster, World Health Organization, Kinshasa, Democratic Republic of the Congo.
Abstract
BACKGROUND: The Democratic Republic of the Congo (DRC) began polio eradication activities in 1996. By 2001, DRC was no longer polio endemic. However, wild poliovirus (WPV) transmission was reestablished in 2006 continuing through 2011 (last WPV case onset 20 December 2011), and vaccine-derived poliovirus type 2 (VDPV2) outbreaks occurred during 2004-2012 (last VDPV2 case onset 4 April 2012). Gaps in acute flaccid paralysis (AFP) surveillance have been consistently documented. METHODS: AFP surveillance indicators were assessed at the national, provincial, and zone de santé (ZS) levels for 2010-2012. A spatiotemporal analysis of compatible, WPV type 1 (WPV1), and VDPV2 cases was performed. RESULTS: During 2010-2012, AFP cases were reported from all provinces but not every ZS, particularly in Equateur province and Province Orientale. A spatiotemporal relationship between compatible, WPV1, and VDPV2 cases was noted. Nonpolio AFP rates met objectives at national and provincial levels but were sub-optimal in certain ZS. National and provincial trends in timely stool collection, stool condition, adequate stool, and 60-day follow-up exams improved. CONCLUSIONS: DRC's AFP surveillance system is functional and improved during 2010-2012. Maintaining improvements and strengthening AFP case detection at the ZS level will provide further support for the apparent interruption of WPV and VDPV2 transmission. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: The Democratic Republic of the Congo (DRC) began polio eradication activities in 1996. By 2001, DRC was no longer polio endemic. However, wild poliovirus (WPV) transmission was reestablished in 2006 continuing through 2011 (last WPV case onset 20 December 2011), and vaccine-derived poliovirus type 2 (VDPV2) outbreaks occurred during 2004-2012 (last VDPV2 case onset 4 April 2012). Gaps in acute flaccid paralysis (AFP) surveillance have been consistently documented. METHODS: AFP surveillance indicators were assessed at the national, provincial, and zone de santé (ZS) levels for 2010-2012. A spatiotemporal analysis of compatible, WPV type 1 (WPV1), and VDPV2 cases was performed. RESULTS: During 2010-2012, AFP cases were reported from all provinces but not every ZS, particularly in Equateur province and Province Orientale. A spatiotemporal relationship between compatible, WPV1, and VDPV2 cases was noted. Nonpolio AFP rates met objectives at national and provincial levels but were sub-optimal in certain ZS. National and provincial trends in timely stool collection, stool condition, adequate stool, and 60-day follow-up exams improved. CONCLUSIONS: DRC's AFP surveillance system is functional and improved during 2010-2012. Maintaining improvements and strengthening AFP case detection at the ZS level will provide further support for the apparent interruption of WPV and VDPV2 transmission. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Entities:
Keywords:
Africa; Democratic Republic of the Congo; acute flaccid paralysis; polio eradication; surveillance; vaccine-derived poliovirus; wild poliovirus
Authors: Nicksy Gumede; Jaume Jorba; Jagadish Deshpande; Mark Pallansch; Riziki Yogolelo; Jean Jacques Muyembe-Tamfum; Olen Kew; Marietjie Venter; Cara C Burns Journal: J Infect Dis Date: 2014-11-01 Impact factor: 5.226
Authors: G Benedetti; M Mossoko; J P Nyakio Kakusu; J Nyembo; J P Mangion; D Van Laeken; R Van den Bergh; W Van den Boogaard; M Manzi; W K Kibango; V Hermans; J Beijnsberger; V Lambert; E Kitenge Journal: Public Health Action Date: 2016-06-21
Authors: Isobel M Blake; Paul Chenoweth; Hiro Okayasu; Christl A Donnelly; R Bruce Aylward; Nicholas C Grassly Journal: Emerg Infect Dis Date: 2016-03 Impact factor: 6.883
Authors: Hugo Kavunga Membo; Aaron Mweene; Serge Alain Sadeuh-Mba; Justin Masumu; Riziki Yogolelo; Norbert Ngendabanyikwa; Eddy Sokolua; Fred Sagamiko; Edgar Simulundu; Steve Ahuka; Jean Jacques Muyembe Journal: Pan Afr Med J Date: 2016-06-22
Authors: Adolphus Clarke; Nicholas Blidi; Bernice Dahn; Chukwuemeka Agbo; Roland Tuopileyi; Monday Julius Rude; George Sie Williams; Mohammed Seid; Alex Gasasira; Zakari Wambai; Laura Skrip; Thomas Nagbe; Tolbert Nyenswah; Joseph Okeibunor Chukwudi; Ticha Johnson; Ambrose Talisuna; Ali Ahmed Yahaya; Soatiana Rajatonirina; Ibrahima Socé Fall Journal: Pan Afr Med J Date: 2019-05-27